General Information of Drug (ID: DMDEJX9)

Drug Name
Reproxalap
Synonyms
2-(3-Amino-6-chloroquinolin-2-yl)propan-2-ol; 2-(3-amino-6-chloroquinolin-2-yl)propan-2-ol; Reproxalap [USAN]; UNII-F0GIZ22IJH; F0GIZ22IJH; SCHEMBL12228833; ALD-102; ADX-102; 2-Quinolinemethanol, 3-amino-6-chloro-alpha,alpha-dimethyl-; NS2
Indication
Disease Entry ICD 11 Status REF
Sjogren-Larsson syndrome 5C52.03 Phase 3 [1]
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 236.7
Logarithm of the Partition Coefficient (xlogp) 2.4
Rotatable Bond Count (rotbonds) 1
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C12H13ClN2O
IUPAC Name
2-(3-amino-6-chloroquinolin-2-yl)propan-2-ol
Canonical SMILES
CC(C)(C1=C(C=C2C=C(C=CC2=N1)Cl)N)O
InChI
InChI=1S/C12H13ClN2O/c1-12(2,16)11-9(14)6-7-5-8(13)3-4-10(7)15-11/h3-6,16H,14H2,1-2H3
InChIKey
GUHFUVLKYSQIOQ-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
16088030
CAS Number
916056-79-6
DrugBank ID
DB16688
TTD ID
D0ZG3S

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Malondialdehyde (MDA) TTZEX7Y NOUNIPROTAC Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)